Perspective Therapeutics CATX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's operating income?
- Perspective Therapeutics (CATX) reported operating income of -$28.28M in Q1 2026.
- How has Perspective Therapeutics's operating income changed year-over-year?
- Perspective Therapeutics's operating income decreased by 29.5% year-over-year, from -$21.83M to -$28.28M.
- What is the long-term trend for Perspective Therapeutics's operating income?
- Over 3 years (2022 to 2025), Perspective Therapeutics's operating income has grown at a 145.3% compound annual growth rate (CAGR), from -$7.69M to -$113.56M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.